Showing 281 - 300 of 1197 results
Following a decade of imaging to support research and clinical trials at ANSTO and the University of Sydney’s Brain and Mind Centre at Camperdown, two PET scanners have been transferred to the University of Wollongong.
Atomic structure of new cathode material for sodium ion batteries helps explain long life
International interest is building in Australia’s new multi-million-dollar radioactive waste processing facility at the Sydney campus of the Australian Nuclear Science and Technology Organisation (ANSTO).
ANSTO can confirm it has completed its 9th successful export of spent fuel. The spent fuel, from OPAL, ANSTO’s multipurpose reactor, has gone to France for reprocessing.
ANSTO is part of collaboration conducting experiments to redefine the kilogram linking it to a fundamental constant of nature.
ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.
The work of the group comprises Radioactivity Measurement Standards, Radioanalytical chemistry, Environmental Radioactivity Measurement Centre, Nuclear security science and Environmental monitoring.
Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,
An investigation that set out to resolve some of the uncertainty in the sources and quantities of pollutants reaching Antarctica has produced a new experimental technique to identify and characterise recently terrestrially-influenced air reaching Antarctica.
ANSTO expertise provides much-needed information about groundwater resources in the Mozambique capital and district.
The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.
Recent research investigating what occurs at the interface of the uranium oxide fuel pellet and the surrounding cladding supports efforts to increase the burnup level of nuclear reactor fuel.
State- of-the-art microdosimeters used in research
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.
